You are here
Generic Sarafem Receives FDA Nod
Fluoxetine Capsules are indicated for the treatment of premenstrual dysphoric disorder (PMDD). They are the AB-rated generic version of Eli Lilly and Company's Sarafem Pulvules Capsules, which had annual U.S. sales of approximately $52 million for the 12 months ending June 30, 2006.
Source: Mylan Laboratories